Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX Treatment of Masseter Muscle Hypertrophy
NCT02010775Phase 2Completed
- Sponsor
- Allergan
- Start
- Jan 2014
- Primary completion
- Mar 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 2 trial of onabotulinumtoxinA in masseter muscle hypertrophy (MMH), sponsored by Allergan. Started Jan 2014; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
masseter muscle hypertrophy (MMH)
Beyond the preview
Go deeper on NCT02010775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02010775.